Medexus Pharmaceuticals Inc.
UPDATE: Cipher Pharmaceuticals - Sun Pharmaceuticals has officially begun marketing of Absorica LD in Canada as of early December
Upcoming - case studies of low-cost OTC drug sales performance post patent expiration & market exclusivity in European markets
Cipher Pharmaceuticals - Piclidenoson
Piclidenoson on deck
UPDATE - Cipher Pharmaceuticals announces NCIB to repurchase 10% of its public float, Launching paid tier.
UPDATE: Cipher Pharmaceuticals - Incidental discovery involving piclidenoson in pre-clinical studies for the treatment of Lowe Syndrome
AirIQ Inc.
A subsidiary of Geo Group Inc. has been supercharged by administrative changes & the border crisis while burgeoning construction costs have left real estate marked 80-90% below replacement costs.
Cipher Pharmaceuticals Inc.
